Stallergenes appoints former Actelion manager as new CEO

PARIS, March 5 (Reuters) - France's Stallergenes said on Wednesday it had appointed former Actelion manager Christian Chavy as its new chief executive to drive the company's expansion into the U.S. immunotherapy market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.